Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

NCT00412919 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER_GOV
Sponsor class

Stopped Lack of efficacy

Conditions

Interventions

Sponsor

Bayside Health